Adverse pregnancy outcomes in gestational diabetes mellitus: a systematic review and meta-analysis protocol

被引:2
作者
Chukwuemeka, Scholarstica [1 ]
Chivese, Tawanda [2 ]
Gopinath, Aswathy [2 ]
Obikeze, Kenechukwu [1 ]
机构
[1] Univ Western Cape, Sch Pharm, Bellville, South Africa
[2] Qatar Univ, Coll Med, Doha, Qatar
来源
BMJ OPEN | 2024年 / 14卷 / 05期
关键词
diabetes in pregnancy; public health; statistics & research methods; diabetes & endocrinology; DIAGNOSIS;
D O I
10.1136/bmjopen-2021-058625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes, including adverse outcomes for both the mother and the fetus. Different diagnostic criteria are used for GDM, and it is not clear how these affect the reported prevalence of adverse pregnancy outcomes. This protocol is for a systematic review to describe and compare the prevalence of adverse pregnancy outcomes in GDM using the different diagnostic criteria applied in various countries/regions of the world. Methods and analysis A systematic review and meta-analysis will be carried out. A comprehensive search of observational studies that report the outcomes of interest to this review from 2010 to 2021 will be conducted. We will search the major electronic databases such as PubMed, Scopus, CINHAL and Google Scholar, and screen references of included studies for additional studies. Meta-analyses will be performed, if there is low heterogeneity, and pooled estimates per outcome reported. We will use the bias-adjusted inverse variance heterogeneity model and random effects models, depending on the heterogeneity observed, to pool prevalence estimates and perform subgroup analyses by region, by age group, by diagnostic criteria and by GDM screening method if sufficient data are available. We will also compare the prevalence of adverse outcomes by diagnostic method and report prevalence ratios. We will report 95% confidence estimates for all estimates. Ethics and dissemination Ethical approval is not required as the review uses published data. Findings will be published in peer-reviewed journals and presented at conferences.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 21 条
  • [1] [Anonymous], 2013, World Health Organization. Geneva
  • [2] Core outcomes in gestational diabetes for treatment trials: The Gestational Metabolic Group treatment set
    Bashir, Mohammed
    Syed, Asma
    Furuya-Kanamori, Luis
    Musa, Omran A. H.
    Mohamed, Aisha M.
    Skarulis, Monica
    Thalib, Lukman
    Konje, Justin C.
    Abou-Samra, Abdul-Badi
    Doi, Suhail A. R.
    [J]. OBESITY SCIENCE & PRACTICE, 2021, 7 (03): : 251 - 259
  • [3] The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis
    Behboudi-Gandevani, Samira
    Amiri, Mina
    Yarandi, Razieh Bidhendi
    Tehrani, Fahimeh Ramezani
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (1)
  • [4] Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
    Bommer, Christian
    Sagalova, Vera
    Heesemann, Esther
    Manne-Goehler, Jennifer
    Atun, Rifat
    Baernighausen, Till
    Davies, Justine
    Vollmer, Sebastian
    [J]. DIABETES CARE, 2018, 41 (05) : 963 - 970
  • [5] High prevalence of cardiovascular risk factors and insulin resistance 6 years after hyperglycemia first detected in pregnancy in Cape Town, South Africa
    Chivese, Tawanda
    Norris, Shane A.
    Levitt, Naomi S.
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [6] Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark
    Damm, Peter
    Houshmand-Oeregaard, Azadeh
    Kelstrup, Louise
    Lauenborg, Jeannet
    Mathiesen, Elisabeth R.
    Clausen, Tine D.
    [J]. DIABETOLOGIA, 2016, 59 (07) : 1396 - 1399
  • [7] Original Unifying the diagnosis of gestational diabetes mellitus: Introducing the NPRP criteria
    Doi, Suhail A. R.
    Bashir, Mohammed
    Sheehan, Michael T.
    Onitilo, Adedayo A.
    Chivese, Tawanda
    Ibrahim, Ibrahim M.
    Beer, Stephen F.
    Furuya-Kanamori, Luis
    Abou-Samra, Abdul-Badi
    McIntyre, H. David
    [J]. PRIMARY CARE DIABETES, 2022, 16 (01) : 96 - 101
  • [8] Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model
    Doi, Suhail A. R.
    Barendregt, Jan J.
    Khan, Shahjahan
    Thalib, Lukman
    Williams, Gail M.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 130 - 138
  • [9] American Diabetes Association "Standards of Medical Care-2020 for Gestational Diabetes Mellitus": A Critical Appraisal
    Goyal, Alpesh
    Gupta, Yashdeep
    Singla, Rajiv
    Kalra, Sanjay
    Tandon, Nikhil
    [J]. DIABETES THERAPY, 2020, 11 (08) : 1639 - 1644
  • [10] Measuring inconsistency in meta-analyses
    Higgins, JPT
    Thompson, SG
    Deeks, JJ
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414): : 557 - 560